Score Overview
Explore the 2021 public Archive ranking β
Where Insmed Inc has ranked, year by year
Showing 1 year ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- INSM
2005: 99.7% Β· 2021: 51.5% Β· free through 2021 Β· longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-30 | $ 114.14 | β |
1 Year2025-09-30 | $ 144.01 | -20.74% |
5 Years2021-09-30 | $ 27.54 | 314.45% |
10 Years2016-09-30 | $ 14.52 | 7x |
20 Years2006-09-29 | $ 13.60 | 8x |
30 Years1996-09-30 | $ 2.44 | 46x |
All Time2000-06-01 | $ 165.00 | -30.82% |
| Period | Last Price2026-09-30 | 1 Year2025-09-30 | 5 Years2021-09-30 | 10 Years2016-09-30 | 20 Years2006-09-29 | 30 Years1996-09-30 | All Time2000-06-01 |
|---|---|---|---|---|---|---|---|
| Price | $ 114.14 | $ 144.01 | $ 27.54 | $ 14.52 | $ 13.60 | $ 2.44 | $ 165.00 |
| Return | β | -20.74% | 314.45% | 7x | 8x | 46x | -30.82% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 1.13B | -$ 875M | $ 1.16B |
| 2025 | $ 606M | -$ 1.27B | $ 1.43B |
| 2024 | $ 363M | -$ 913M | $ 1.43B |
| 2023 | $ 305M | -$ 749M | $ 780M |
| 2022 | $ 245M | -$ 481M | $ 1.14B |
| 2021 | $ 188M | -$ 434M | $ 716M |
| 2020 | $ 164M | -$ 294M | $ 532M |
| 2019 | $ 136M | -$ 254M | $ 487M |
| 2018 | $ 9M | -$ 324M | $ 495M |
| 2017 | $ 0.00 | -$ 192M | $ 381M |
| 2016 | $ 0.00 | -$ 176M | $ 162M |
| 2015 | $ 0.00 | -$ 118M | $ 282M |
| 2014 | $ 11M | -$ 79M | $ 159M |
| 2013 | $ 11M | -$ 56M | $ 113M |
| 2012 | $ 0.00 | -$ 41M | $ 92M |
| 2011 | $ 4M | -$ 59M | $ 76M |
| 2010 | $ 6M | -$ 6M | $ 108M |
| 2009 | $ 10M | $ 118M | $ 122M |
| 2008 | $ 11M | -$ 15M | $ 2M |
| 2007 | $ 7M | -$ 19M | $ 16M |
| 2006 | $ 991K | -$ 56M | $ 24M |
| 2005 | $ 131K | -$ 40M | $ 18M |
| 2004 | $ 137K | -$ 27M | $ 9M |
| 2003 | $ 150K | -$ 10M | $ 29M |
| 2002 | $ 1M | -$ 36M | $ 27M |
| 2001 | $ 296K | -$ 37M | $ 51M |
| IPO2000 | $ 60K | -$ 79M | $ 83M |

Insmed Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 164M to $ 606M and net income went from -$ 294M to -$ 1.27B. Revenue increased in every one of those 5 years; net income in 1.
Across Insmed Inc's full reported history, from 2000 to 2025, revenue grew from $ 60K to $ 606M and net income went from -$ 79M to -$ 1.27B. Revenue increased in 58% of the years measured; net income in 35%.
Insmed Inc currently holds a 20-year HDB Score of 2.8 out of 10. How the HDB Score is calculated.
Membership
Continue INSMβs history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,814 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio




